Dr. Richard Kirk Englehardt, MD

Dr. Englehardt practices at Huebner Ambulatory Surgery Center in San Antonio, Texas.

Dr. Englehardt's NPI, 1225251002, was assigned on April 10, 2007. Dr. Englehardt graduated from Carver College of Medicine in 2006. Dr. Englehardt's Michigan license number on file is 4301088233.

Dr. Englehardt's primary practice is Huebner Ambulatory Surgery Center, at 9618 Huebner Road Suite 111, San Antonio, TX 78240. The practice phone is (972) 352-3795.

Dr. Englehardt's primary practice is Huebner Ambulatory Surgery Center in San Antonio, Texas. Dr. Englehardt is also affiliated with Methodist Hospital. The medical group on file is BMI of Texas. Dmand AI also links Dr. Englehardt to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Englehardt practices, 5 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Englehardt's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Englehardt is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Englehardt's licenses on file in 2 states: Michigan and Texas.

Dmand AI lists abdominal adhesion surgery, abdominal hernia repair surgery, bariatric surgery, esophagus, stomach, or upper small intestine surgery, gallbladder removal, groin hernia surgery and upper GI endoscopy among the conditions Dr. Englehardt treats.

CMS data shows 339 Medicare services from Dr. Englehardt across 8 procedure codes in 2024, for 153 Medicare patients. Medicare paid $45,828 for them.

CMS counts 153 Medicare patients who saw Dr. Englehardt in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Englehardt's median patient age at 54, with 76% women.

In 2024, Dr. Englehardt wrote 488 Medicare Part D claims for 93 patients. 86% of them were for generic drugs. CMS names the drug for 362 of them, across 11 drugs with 11 or more claims each, at $14,677 in total drug cost. In 2023, CMS named 203 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 65 out of 100 for Dr. Englehardt for performance year 2024, reported as part of a group. CMS lists Dr. Englehardt as offering telehealth. CMS counts 51 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Englehardt, more than 64% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Englehardt, published from 2002 to 2022. The most frequent topics are Laparoscopy. Dr. Englehardt's most frequent co-authors are Lishan Aklog, MD, Seper Dezfoli, MD and Frank Dauterive Duperier, MD.

Dmand AI links Dr. Englehardt to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Gastroesophageal Reflux and Esophageal Motility Disorders.

CMS Open Payments shows 408 general payments to Dr. Englehardt from 43 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Medical Device Business Services, Inc. paid the most, $58,716.

Dmand AI lists 2 awards for Dr. Englehardt, most recently Fellow (FASMBS) in 2015.

Dr. Englehardt graduated from Carver College of Medicine in 2006. Dr. Englehardt is a member of ACS, ASMBS and SAGES.

Dr. Englehardt is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.